Learn More
Invitrogen™ SETDB2 Polyclonal Antibody

Description
PA5-19436 targets CLLD8/SETDB2 in IHC (P) and WB applications and shows reactivity with Human samples. The PA5-19436 immunogen is synthetic peptide conjugated to KLH derived from within residues 550 - 650 of Human CLLD8/SETDB2.
Specifications
Specifications
| Antigen | SETDB2 |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% sodium azide; pH 7.4 |
| Gene | SETDB2 |
| Gene Accession No. | Q96T68 |
| Gene Alias | bifurcated 2; C13orf4; Chronic lymphocytic leukemia deletion region gene 8 protein; Clld8; CLLL8; CLLL8 protein; DKFZp586I0123; DKFZp761J1217; Gm293; Histone-lysine N-methyltransferase SETDB2; KMT1F; Lysine N-methyltransferase 1F; SET domain; SET domain bifurcated 2; SET domain, bifurcated 2; Setdb2; Setdb2-Phf11-1-Phf11-2 fusion |
| Gene Symbols | SETDB2 |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.